000			01862 a2200553 4500
005			20250515085121.0
264		0	_c20080815
008			200808s 0 0 eng d
022			_a0022-3549
024	7		_a10.1002/jps.21148 _2doi
040			_aNLM _beng _cNLM
100	1		_aHe, Weiling
245	0	0	_aPreparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. _h[electronic resource]
260			_bJournal of pharmaceutical sciences _cJun 2008
300			_a2250-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAnimals
650	0	4	_aBiological Availability
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCells, Cultured
650	0	4	_aChemical Precipitation
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aDelayed-Action Preparations
650	0	4	_aDrug Carriers
650	0	4	_aDrug Compounding
650	0	4	_aEnbucrilate _xchemistry
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aImmunologic Factors _xadministration & dosage
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aModels, Chemical
650	0	4	_aNanoparticles
650	0	4	_aParticle Size
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aSolubility
650	0	4	_aSurface Properties
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aTechnology, Pharmaceutical _xmethods
650	0	4	_aThymopentin _xadministration & dosage
700	1		_aJiang, Xuehua
700	1		_aZhang, Zhi-Rong
773	0		_tJournal of pharmaceutical sciences _gvol. 97 _gno. 6 _gp. 2250-9
856	4	0	_uhttps://doi.org/10.1002/jps.21148 _zAvailable from publisher's website
999			_c17380870 _d17380870